encalaeret nda
3 Rare Disease Data Center Breakthroughs Spark BridgeBio Surge
BridgeBio’s shares jumped 5.8% when its new Rare Disease Data Center cut bioprocess modeling time by 40%, directly tightening investment forecasts. The center unifies patient registries, genomic datasets, and analytics, delivering faster trial enrollment and clearer market signals. Investors see a faster path from data to revenue. Financial